{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:06:25Z","timestamp":1790179585929,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iLIVER"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.iliver.2026.100260","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:43:24Z","timestamp":1787787804000},"page":"100260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the role of hypoxia inducible factors in liver fibrosis and future therapeutic applications"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0199-4763","authenticated-orcid":false,"given":"Yasha","family":"Taimuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-241X","authenticated-orcid":false,"given":"Riaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.iliver.2026.100260_bib1","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akk\u0131z","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.iliver.2026.100260_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21037\/tgh.2020.02.21","article-title":"Fibrosis and hepatic regeneration mechanism","volume":"7","author":"Zu\u00f1iga-Aguilar","year":"2022","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib3","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s11033-020-05290-0","article-title":"Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment","volume":"47","author":"Zadorozhna","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18231\/j.ijpca.2024.001","article-title":"Overview: global burden of liver disease","volume":"11","author":"Baviskar","year":"2024","journal-title":"IJPCA"},{"issue":"24","key":"10.1016\/j.iliver.2026.100260_bib5","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.82.24.8681","article-title":"Hepatic lipocytes: the principal collagen-producing cells of normal rat liver","volume":"82","author":"Friedman","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J Cell Mol Med"},{"issue":"9","key":"10.1016\/j.iliver.2026.100260_bib7","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.90.9.4304","article-title":"General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.iliver.2026.100260_bib8","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexmp.2004.08.002","article-title":"Liver hypoxia and lack of recovery after reperfusion at high blood alcohol levels in the intragastric feeding model of alcohol liver disease","volume":"77","author":"Li","year":"2004","journal-title":"Exp Mol Pathol"},{"issue":"14","key":"10.1016\/j.iliver.2026.100260_bib10","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1alpha is mediated by an O2- dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.iliver.2026.100260_bib11","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1067\/mai.2003.108","article-title":"2. cytokines and chemokines","volume":"111","author":"Borish","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.iliver.2026.100260_bib13","first-page":"3810","article-title":"Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition","volume":"117","author":"Higgins","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.iliver.2026.100260_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative stress: harms and benefits for human health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"10.1016\/j.iliver.2026.100260_bib15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1089\/ars.2007.1628","article-title":"Detection and characterization of tumor hypoxia using pO2 histography","volume":"9","author":"Vaupel","year":"2007","journal-title":"Antioxid Redox Signaling"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0022-3565(25)38815-4","article-title":"New, simple models to evaluate zone-specific damage due to hypoxia in the perfused rat liver: time course and effect of nutritional state","volume":"236","author":"Bradford","year":"1986","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"6","key":"10.1016\/j.iliver.2026.100260_bib17","first-page":"1","article-title":"Metabolic reprogramming in the tumor microenvironment of liver cancer","volume":"17","author":"Lin","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/toxsci\/kfh011","article-title":"Modes of cell death in rat liver after monocrotaline exposure","volume":"77","author":"Copple","year":"2004","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1432-1327.1998.2530743.x","article-title":"Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state","volume":"253","author":"Arteel","year":"1998","journal-title":"Eur J Biochem"},{"issue":"5","key":"10.1016\/j.iliver.2026.100260_bib20","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1053\/jhep.2002.32524","article-title":"Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis","volume":"35","author":"Corpechot","year":"2002","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.iliver.2026.100260_bib21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nm.4412","article-title":"Activation of intestinal hypoxia-inducible factor 2\u03b1 during obesity contributes to hepatic steatosis","volume":"23","author":"Xie","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.iliver.2026.100260_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2022.100177","article-title":"Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents","volume":"14","author":"Hazlehurst","year":"2022","journal-title":"Metabol Open"},{"issue":"7","key":"10.1016\/j.iliver.2026.100260_bib23","first-page":"1604","article-title":"Mechanism of action of hypoxia-inducible factor 1\u03b1 in the development and progression of liver fibrosis","volume":"35","author":"Zhou","year":"2019","journal-title":"J Clin Hepatol"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib24","doi-asserted-by":"crossref","first-page":"G582","DOI":"10.1152\/ajpgi.90368.2008","article-title":"Reduced liver fibrosis in hypoxia-inducible factor-1\u03b1-deficient mice","volume":"296","author":"Moon","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13062-023-00428-z","article-title":"Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1\/2-CREB axis","volume":"18","author":"Liu","year":"2023","journal-title":"Biol Direct"},{"issue":"10\u201312","key":"10.1016\/j.iliver.2026.100260_bib26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbagrm.2010.07.004","article-title":"Small molecule regulators of Rb-E2F pathway as modulators of transcription","volume":"1799","author":"Singh","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.iliver.2026.100260_bib27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.cellsig.2014.01.008","article-title":"Promising roles of mammalian E2Fs in hepatocellular carcinoma","volume":"26","author":"Zhan","year":"2014","journal-title":"Cell Signal"},{"issue":"5","key":"10.1016\/j.iliver.2026.100260_bib28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0168-8278(99)80147-0","article-title":"Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats","volume":"30","author":"Assy","year":"1999","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.iliver.2026.100260_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/jsre.1999.5627","article-title":"Fibroblast response to hypoxia: the relationship between angiogenesis and matrix regulation","volume":"84","author":"Steinbrech","year":"1999","journal-title":"J Surg Res"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1055\/s-0030-1255355","article-title":"Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease","volume":"30","author":"Rosmorduc","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.iliver.2026.100260_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.24400","article-title":"Hypoxia-inducible transcription factor 2\u03b1 promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis","volume":"54","author":"Qu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.iliver.2026.100260_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8323747","article-title":"Regulation of hepatic stellate cells and fibrogenesis by fibroblast growth factors","author":"Schumacher","year":"2016","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2012.08.036","article-title":"Functional and structural features of adipokine family","volume":"61","author":"Raucci","year":"2013","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.iliver.2026.100260_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","article-title":"Angiogenesis in chronic liver disease and its complications: angiogenesis in CLD","volume":"31","author":"Coulon","year":"2011","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib35","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/hep.30294","article-title":"Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease","volume":"69","author":"Lefere","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.iliver.2026.100260_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/biomedicines6020056","article-title":"Hypoxia, metabolism and immune cell function","volume":"15","author":"Krzywinska","year":"2018","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.iliver.2026.100260_bib37","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.iliver.2026.100260_bib38","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1530-0277.2010.01422.x","article-title":"Leptin and acetaldehyde synergistically promotes \u03b1SMA expression in hepatic stellate cells by an interleukin 6-dependent mechanism","volume":"35","author":"Liu","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"10.1016\/j.iliver.2026.100260_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3390\/biom12050635","article-title":"The synergistic cooperation between TGF-\u03b2 and hypoxia in cancer and fibrosis","volume":"12","author":"Mallikarjuna","year":"2022","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.iliver.2026.100260_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1124\/jpet.111.189340","article-title":"Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice","volume":"341","author":"Copple","year":"2012","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"4","key":"10.1016\/j.iliver.2026.100260_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1008942828960","article-title":"Conditional gene targeting in macrophages and granulocytes using LysMcre mice","volume":"8","author":"Clausen","year":"1999","journal-title":"Transgenic Res"},{"issue":"5","key":"10.1016\/j.iliver.2026.100260_bib42","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1872-034X.2010.00635.x","article-title":"Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic Kupffer cells","volume":"40","author":"Copple","year":"2010","journal-title":"Hepatol Res"},{"issue":"8","key":"10.1016\/j.iliver.2026.100260_bib43","article-title":"Hypoxia-inducible factors as key players in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"6","author":"Holzner","year":"2021","journal-title":"Front Med"},{"issue":"10","key":"10.1016\/j.iliver.2026.100260_bib44","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1258\/ebm.2012.012106","article-title":"Oxidative stress contributes to liver damage in a murine model of alpha-1-antitrypsin deficiency","volume":"237","author":"Marcus","year":"2012","journal-title":"Exp Biol Med"},{"issue":"2","key":"10.1016\/j.iliver.2026.100260_bib45","first-page":"731","article-title":"SLC7A11 in fibrosis: molecular mechanisms and future prospects","volume":"17","author":"Juntong","year":"2026","journal-title":"Aging and Disease"},{"issue":"4","key":"10.1016\/j.iliver.2026.100260_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-2002-26761","article-title":"Oxidative stress, plant-derived antioxidants and liver fibrosis","volume":"68","author":"Gebhardt","year":"2002","journal-title":"Planta Med"},{"key":"10.1016\/j.iliver.2026.100260_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cbi.2014.10.005","article-title":"Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-\u03b2\/Smad signaling pathway","volume":"224","author":"Lee","year":"2014","journal-title":"Chem Biol Interact"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jtcme.2017.07.002","article-title":"Herbal remedies for liver fibrosis: a review on the mode of action of fifty herbs","volume":"8","author":"Latief","year":"2018","journal-title":"J Tradit Complement Med"},{"key":"10.1016\/j.iliver.2026.100260_bib49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.fitote.2014.10.009","article-title":"Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1\u03b1 through mTOR-dependent pathway","volume":"99","author":"Zhao","year":"2014","journal-title":"Fitoterapia"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib50","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.104.079616","article-title":"Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms","volume":"313","author":"Biecker","year":"2005","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"20","key":"10.1016\/j.iliver.2026.100260_bib51","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1073\/pnas.95.20.11715","article-title":"Mitochondrial reactive oxygen species trigger hypoxia-induced transcription","volume":"95","author":"Chandel","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.iliver.2026.100260_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cbi.2018.02.025","article-title":"Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha","volume":"285","author":"Jin","year":"2018","journal-title":"Chem Biol Interact"},{"issue":"11","key":"10.1016\/j.iliver.2026.100260_bib53","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/abbs\/gmt099","article-title":"Gene expression profiles of sodium-dependent vitamin C transporters in mice after alcohol consumption","volume":"45","author":"Guo","year":"2013","journal-title":"Acta Biochim Biophys Sin"},{"issue":"5","key":"10.1016\/j.iliver.2026.100260_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.12594","article-title":"Resveratrol attenuates Nitrosodiethylamine-induced liver injury in anti-inflammatory mannerviaregulating cyclooxygenase-2","volume":"42","author":"Mukherjee","year":"2018","journal-title":"J Food Biochem"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/1319-3767.96445","article-title":"Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches","volume":"18","author":"Ahmad","year":"2012","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.iliver.2026.100260_bib56","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12906-015-0862-6","article-title":"Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice","volume":"15","author":"Zhou","year":"2015","journal-title":"BMC Compl Alternative Med"},{"issue":"6","key":"10.1016\/j.iliver.2026.100260_bib57","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.21873\/anticanres.13400","article-title":"Traditional Chinese medicine (TCM) Astragalus membranaceus and Curcuma wenyujin promote vascular normalization in tumor-derived endothelial cells of human hepatocellular carcinoma","volume":"39","author":"Zang","year":"2019","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.iliver.2026.100260_bib58","article-title":"The suppressive effect of resveratrol on HIF-1\u03b1 and VEGF expression after warm ischemia and reperfusion in rat liver","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.iliver.2026.100260_bib59","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1111\/jcmm.14543","article-title":"Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis","volume":"23","author":"Feng","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"8","key":"10.1016\/j.iliver.2026.100260_bib60","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/mc.22369","article-title":"Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells","volume":"55","author":"Dai","year":"2016","journal-title":"Mol Carcinog"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib61","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7150\/thno.22237","article-title":"Ligand activation of PPAR\u03b3 by Ligustrazine suppresses pericyte functions of hepatic stellate cells via SMRT-mediated transrepression of HIF-1\u03b1","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12762","article-title":"Curcumol attenuates liver sinusoidal endothelial cell angiogenesis via regulating Glis-PROX1-HIF-1\u03b1 in liver fibrosis","volume":"53","author":"Yang","year":"2020","journal-title":"Cell Prolif"},{"issue":"5","key":"10.1016\/j.iliver.2026.100260_bib63","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.3892\/mmr.2014.2574","article-title":"Saikosaponin-d suppresses the expression of cyclooxygenase-2 through the phospho-signal transducer and activator of transcription 3\/hypoxia-inducible factor-1\u03b1 pathway in hepatocellular carcinoma cells","volume":"10","author":"He","year":"2014","journal-title":"Mol Med Rep"},{"issue":"15","key":"10.1016\/j.iliver.2026.100260_bib64","doi-asserted-by":"crossref","first-page":"20193","DOI":"10.18632\/oncotarget.7935","article-title":"Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1\u03b1 via the PI3K\/AKT\/mTOR pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.iliver.2026.100260_bib65","doi-asserted-by":"crossref","first-page":"G387","DOI":"10.1152\/ajpgi.00054.2019","article-title":"Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation","volume":"317","author":"Zhao","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.iliver.2026.100260_bib66","article-title":"Melittin inhibits hypoxia-induced vasculogenic mimicry formation and epithelial-mesenchymal transition through suppression of HIF-1\u03b1\/Akt pathway in liver cancer","author":"Chen","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib67","article-title":"Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3\/HIF-1\u03b1\/VEGF signalling","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib68","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1096\/fj.04-2175com","article-title":"Apigenin inhibits VEGF and HIF-1 expression via PI3K\/AKT\/p70S6K1 and HDM2\/p53 pathways","volume":"19","author":"Fang","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.iliver.2026.100260_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172785","article-title":"Antiosteoporotic activities of isoquercitrin in ovariectomized rats: role of inhibiting hypoxia inducible factor-1 alpha","volume":"865","author":"Fayed","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.iliver.2026.100260_bib70","first-page":"3430","article-title":"Hovenia dulcis Thunb. and its active compound ampelopsin inhibit angiogenesis through suppression of VEGFR2 signaling and HIF-1\u03b1 expression","volume":"38","author":"Han","year":"2017","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib71","first-page":"2248","article-title":"Effects and significance of formononetin on expression levels of HIF-1\u03b1 and VEGF in mouse cervical cancer tissue","volume":"18","author":"Zhang","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.iliver.2026.100260_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nutres.2019.02.004","article-title":"Luteolin improves myocardial cell glucolipid metabolism by inhibiting hypoxia inducible factor-1\u03b1 expression in angiotensin II\/hypoxia-induced hypertrophic H9c2 cells","volume":"65","author":"Wang","year":"2019","journal-title":"Nutr Res"},{"issue":"10","key":"10.1016\/j.iliver.2026.100260_bib73","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.18240\/ijo.2019.10.04","article-title":"Inhibition of Obtusifolin on retinal pigment epithelial cell growth under hypoxia","volume":"12","author":"Wang","year":"2019","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib74","first-page":"79","article-title":"Cervical cancer cell proliferation inhibition by vanillin oxime through HIF-1\u03b1 expression inhibition, ERK1\/2 and Akt protein down-regulation","volume":"69","author":"Chen","year":"2022","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.iliver.2026.100260_bib75","doi-asserted-by":"crossref","unstructured":"Xingxun B, Jinhua H, Yan Z, et al. Advances on the anti-tumor mechanisms of the carotenoid Crocin. PeerJ. 11: e15535. http:\/\/doi.org\/10.7717\/peerj.15535.","DOI":"10.7717\/peerj.15535"},{"issue":"6","key":"10.1016\/j.iliver.2026.100260_bib76","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.3390\/md13063514","article-title":"Fucoidan Suppresses hypoxia-induced lymphangiogenesis and lymphatic metastasis in mouse hepatocarcinoma","volume":"13","author":"Teng","year":"2015","journal-title":"Mar Drugs"},{"key":"10.1016\/j.iliver.2026.100260_bib77","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2015.12.020","article-title":"\u03b1-Solanine inhibits vascular endothelial growth factor expression by down-regulating the ERK1\/2-HIF-1\u03b1 and STAT3 signaling pathways","volume":"771","author":"Wen","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.iliver.2026.100260_bib78","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.immuni.2016.09.013","article-title":"Deficient activity of the nuclease MRE11A induces T cell aging and promotes arthritogenic effector functions in patients with rheumatoid arthritis","volume":"45","author":"Li","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.iliver.2026.100260_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1703982","article-title":"Ginsenoside potential targeting hypoxia-inducible factor-1\u03b1 as promising therapeutics for cancer: a review","volume":"12","author":"Ai","year":"2026","journal-title":"Front Med"},{"issue":"21","key":"10.1016\/j.iliver.2026.100260_bib80","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.3390\/ijms20215384","article-title":"The molecular effects of sulforaphane and capsaicin on metabolism upon androgen and Tip 60 activation of androgen receptor","volume":"20","author":"Carrasco-Pozo","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib81","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0026-895X(24)05644-X","article-title":"Berberine inhibits HIF-1alpha expression via enhanced proteolysis","volume":"66","author":"Lin","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.iliver.2026.100260_bib82","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1472-6882-12-160","article-title":"Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells","volume":"12","author":"Law","year":"2012","journal-title":"BMC Compl Alternative Med"},{"issue":"28","key":"10.1016\/j.iliver.2026.100260_bib83","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1021\/acs.jafc.9b03027","article-title":"Sulforaphane inhibits nonmuscle invasive bladder cancer cells proliferation through suppression of HIF-1\u03b1-mediated glycolysis in hypoxia","volume":"67","author":"Xia","year":"2019","journal-title":"J Agric Food Chem"},{"issue":"9","key":"10.1016\/j.iliver.2026.100260_bib84","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3389\/fphar.2018.01455","article-title":"Isoliquiritin apioside suppresses in vitro invasiveness and angiogenesis of cancer cells and endothelial cells","volume":"10","author":"Kim","year":"2018","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib85","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/carcin\/bgr320","article-title":"Hypoxia-inducible factor-1\u03b1 inhibition by a pyrrolopyrazine metabolite of oltipraz as a consequence of microRNAs 199a-5p and 20a induction","volume":"33","author":"Kang","year":"2012","journal-title":"Carcinogenesis"},{"issue":"18","key":"10.1016\/j.iliver.2026.100260_bib86","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/onc.2010.587","article-title":"Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death","volume":"30","author":"Kucejova","year":"2011","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.iliver.2026.100260_bib87","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/hep.29754","article-title":"Hypoxia-inducible factor 2\u03b1 drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein","volume":"67","author":"Morello","year":"2018","journal-title":"Hepatology"},{"issue":"49","key":"10.1016\/j.iliver.2026.100260_bib88","doi-asserted-by":"crossref","first-page":"86206","DOI":"10.18632\/oncotarget.21039","article-title":"Modulation of HIF-1\u03b1 and STAT3 signaling contributes to anti-angiogenic effect of YC-1 in mice with liver fibrosis","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.iliver.2026.100260_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156774","article-title":"HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy","volume":"132","author":"Salman","year":"2022","journal-title":"J Clin Investig"},{"issue":"12","key":"10.1016\/j.iliver.2026.100260_bib90","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx 4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib91","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis","volume":"53","author":"Wang","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.iliver.2026.100260_bib92","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1038\/s41598-017-03744-3","article-title":"SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells","volume":"7","author":"Novo","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.iliver.2026.100260_bib93","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/gut.52.9.1347","article-title":"Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis","volume":"52","author":"Yoshiji","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.iliver.2026.100260_bib94","first-page":"300","article-title":"New insight into the anti-liver fibrosis effect of multitargeted tyrosine kinase inhibitors: from molecular target to clinical trials","volume":"6","author":"Qu","year":"2015","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib95","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/CAD.0000000000000316","article-title":"Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways","volume":"27","author":"Hao","year":"2016","journal-title":"Anti Cancer Drugs"},{"issue":"7","key":"10.1016\/j.iliver.2026.100260_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069309","article-title":"Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.iliver.2026.100260_bib97","series-title":"Stellate Cells in Health and Disease","first-page":"107","author":"Gandhi","year":"2015"},{"issue":"7","key":"10.1016\/j.iliver.2026.100260_bib98","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11626-013-9637-x","article-title":"In vitro interactions between rat bone marrow-derived endothelial progenitor cells and hepatic stellate cells: interaction between EPCs and HSCs","volume":"49","author":"Liu","year":"2013","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/liv.12975","article-title":"Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives","volume":"36","author":"Salomone","year":"2016","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.iliver.2026.100260_bib100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00109-016-1408-1","article-title":"Hypoxia-inducible factors as molecular targets for liver diseases","volume":"94","author":"Ju","year":"2016","journal-title":"J Mol Med (Berl)"},{"issue":"10","key":"10.1016\/j.iliver.2026.100260_bib101","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1007\/s10620-008-0605-3","article-title":"Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma","volume":"54","author":"Wang","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib102","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/onc.2008.398","article-title":"Silibinin inhibits hypoxia-inducible factor-1\u03b1 and mTOR\/p70S6K\/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy","volume":"28","author":"Garc\u00eda-Maceira","year":"2009","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.iliver.2026.100260_bib103","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1142\/S0192415X2350057X","article-title":"Paeoniflorin coordinates macrophage polarization and mitigates liver inflammation and fibrogenesis by targeting the NF-[formula: see text] B\/HIF-1\u03b1 pathway in CCl4-induced liver fibrosis","volume":"51","author":"Liu","year":"2023","journal-title":"Am J Chin Med"},{"issue":"2","key":"10.1016\/j.iliver.2026.100260_bib104","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3892\/etm.2017.4033","article-title":"Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad 7 and PPAR-\u03b3","volume":"13","author":"Zhou","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.iliver.2026.100260_bib105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jnutbio.2015.09.015","article-title":"Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL\/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt","volume":"28","author":"Jia","year":"2016","journal-title":"J Nutr Biochem"},{"issue":"6","key":"10.1016\/j.iliver.2026.100260_bib106","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1053\/j.gastro.2006.01.038","article-title":"Toll-like receptor signaling in the liver","volume":"130","author":"Schwabe","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.iliver.2026.100260_bib107","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/cas.14010","article-title":"Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma","volume":"110","author":"Umezaki","year":"2019","journal-title":"Cancer Sci"},{"issue":"10","key":"10.1016\/j.iliver.2026.100260_bib114","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.iliver.2026.100260_bib108","first-page":"3997","article-title":"Hypoxia-inducible factor 1\u03b1 and ROCK1 regulate proliferation and collagen synthesis in hepatic stellate cells under hypoxia","volume":"18","author":"Hu","year":"2018","journal-title":"Mol Med Rep"},{"issue":"s1","key":"10.1016\/j.iliver.2026.100260_bib109","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1111\/j.1440-1746.2006.04665.x","article-title":"Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice","volume":"22","author":"Watanabe","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.iliver.2026.100260_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101135","article-title":"Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR\/HIF-1\u03b1 signaling pathway","volume":"28","author":"Yang","year":"2023","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.iliver.2026.100260_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115279","article-title":"Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K\/AKT\/mTOR and HIF-1\/VEGF cascade","volume":"165","author":"He","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"10.1016\/j.iliver.2026.100260_bib112","doi-asserted-by":"crossref","first-page":"321","DOI":"10.31083\/j.fbl2909321","article-title":"A new target for hepatic fibrosis prevention and treatment: the Warburg effect","volume":"29","author":"Pan","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"12","key":"10.1016\/j.iliver.2026.100260_bib113","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib115","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202012097","article-title":"pVHL-mediated SMAD3 degradation suppresses TGF-\u03b2 signaling","volume":"221","author":"Zhou","year":"2022","journal-title":"J Cell Biol"},{"issue":"23","key":"10.1016\/j.iliver.2026.100260_bib116","doi-asserted-by":"crossref","first-page":"16297","DOI":"10.18632\/oncotarget.24631","article-title":"VHL status regulates transforming growth factor-\u03b2 signaling pathways in renal cell carcinoma","volume":"9","author":"Mallikarjuna","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.iliver.2026.100260_bib117","article-title":"Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2024.100140","article-title":"Emerging role of natural bioactive compounds in navigating the future of liver disease","volume":"4","author":"Chaudhary","year":"2025","journal-title":"iLIVER"},{"key":"10.1016\/j.iliver.2026.100260_bib119","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14299","article-title":"Hypoxia-induced factor and its role in liver fibrosis","volume":"10","author":"Mohammad Omar","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.iliver.2026.100260_bib120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fphar.2016.00033","article-title":"Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis","volume":"7","author":"Schon","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.iliver.2026.100260_bib121","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.actbio.2023.07.035","article-title":"Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles","volume":"168","author":"Xiang","year":"2023","journal-title":"Acta Biomater"},{"key":"10.1016\/j.iliver.2026.100260_bib122","doi-asserted-by":"crossref","first-page":"9641","DOI":"10.2147\/IJN.S524078","article-title":"Nanomedicines in the treatment of liver fibrosis: a review","volume":"20","author":"Du","year":"2025","journal-title":"Int J Nanomed"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib123","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13765-025-01007-8","article-title":"Design, synthesis, and biological evaluation of ACF-03: a novel anti-fibrotic and antioxidant agent targeting ROS-TGF-\u03b21-HIF-1\u03b1 axis","volume":"68","author":"Abeysiriwardhana","year":"2025","journal-title":"Appl Biol Chem"},{"issue":"3","key":"10.1016\/j.iliver.2026.100260_bib124","first-page":"304","article-title":"Antihepatic fibrosis drugs in clinical trials","volume":"8","author":"Guo","year":"2020","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"10.1016\/j.iliver.2026.100260_bib125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","article-title":"Targeted protein degradation: advances in drug discovery and clinical practice","volume":"9","author":"Zhong","year":"2024","journal-title":"Signal Transduct Targeted Ther"}],"container-title":["iLIVER"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947826000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947826000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:42:54Z","timestamp":1790178174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772947826000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":125,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2772947826000447"],"URL":"https:\/\/doi.org\/10.1016\/j.iliver.2026.100260","relation":{},"ISSN":["2772-9478"],"issn-type":[{"value":"2772-9478","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the role of hypoxia inducible factors in liver fibrosis and future therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"iLIVER","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iliver.2026.100260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}],"article-number":"100260"}}